Site Search
Professionals 360 results
Capabilities 79 results
Practice Area
Winston’s Intellectual Property (IP) Practice is one of the most active and highly regarded in the United States per Chambers USA, Benchmark Litigation US, and Best Law Firms®, among other ranking organizations. Our team features some of the country’s best IP lawyers, attorneys with the technical abilities to litigate and try highly complex IP disputes, and technical lawyers who provide critical advisory services.
Practice Area
We routinely help clients protect and commercialize their intellectual property (IP) assets and provide due diligence on complex technology and IP transactions. We negotiate and draft IP licenses and transfers; provide strategic guidance on optimal structures for IP and IT transactions; and evaluate copyright, trademark, and patent portfolios and provide related due diligence activities in connection with IPOs, mergers and acquisitions, private equity investments, licenses, and other corporate transactions.
Practice Area
As society and business become even more digitalized, technology and intellectual property (IP) have become key focal points for businesses. Our Technology Antitrust Group combines the cross-practice and cross-office experience of our lawyers to assist clients in successfully navigating the dynamic convergence of technology, antitrust, and IP law. We understand the challenges presented by the ever-changing digital landscape and are committed to providing our clients with tailored solutions to address their specific needs.
Experience 99 results
Experience
|January 29, 2025
Drugs Made In America Acquisition Corp. Announces Closing of $200,000,000 Initial Public Offering
Experience
|December 19, 2024
Winston & Strawn Represents Estrella Immunopharma in US$100 Million Shelf Registration
Experience
|November 12, 2024
Insights & News 1,830 results
Seminar/CLE
|May 13, 2025
2025 Health Care & Life Sciences Summit
Winston & Strawn is pleased to host its fifth annual Health Care & Life Sciences Summit. Clients and friends of the firm are invited to join us to network with peers and gain insights from industry leaders and legal experts. The summit will take place live at our Chicago office, and CLE-eligible recordings of the Summit’s sessions will be available shortly following the event.
Speaking Engagement
|May 9, 2025
Join Winston & Strawn partners M. Imad Khan and Keerthika M. Subramanian for the upcoming online program “Hot Topics in International Arbitration and Strategic Transactions: Recent Developments and Key Trends in India” hosted by the Practising Law Insititute.
Sponsorship
|April 15, 2025
Winston & Strawn Sponsors, Michael Blankenship Speaks at 2025 IPO Summit
Winston & Strawn is proud to sponsor the upcoming 2025 IPO Summit, a premier event designed for small-cap and micro-cap companies preparing for an IPO on a U.S. senior exchange.
Other Results 60 results
Law Glossary
Where Is a List of Biosimilar Drugs and Biologics That Have Been Approved in the U.S.?
The FDA maintains a list of biosimilar drugs that have been approved in the USA. This list can be found here.
Site Content
Location
Since opening in 2011, Winston & Strawn’s Houston office has grown to nearly 60 lawyers and is home to many long-standing leaders of the Houston legal and business communities. Our Houston office hosts a comprehensive transactional team specializing in private equity, capital markets, and public companies, as well as extensive commercial litigation and intellectual property practices—with nearly all Houston IP attorneys possessing technical degrees. We are also home to a leading energy and infrastructure group that focuses on oil and gas projects and infrastructure litigation, and an international arbitration practice. Our robust offerings demonstrate our commitment to the continued growth of the city’s global, economic, and cultural footprint.